Small but very interesting: a new personalized T cell therapy in advanced metastatic #melanoma. Feasibility is demonstrated for this new #immunotherapy, but production time is
still around 19 weeks. Disease stabilisation is observed and immune responses could be measured.
#Oncology #Immunology #science #health
@chfloudas
https://www.nature.com/articles/s41591-024-03418-4
@halama_immuno very interesting, thanks for sharing